About Josephine Schrøder

This author has not yet filled in any details.
So far Josephine Schrøder has created 12 blog entries.

Arxx Therapeutics

Arxx Therapeutics develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis

Arxx Therapeutics2021-09-27T13:06:15+00:00
Go to Top